Literature DB >> 26617181

How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?

Steve Balsis1, Jared F Benge2, Deborah A Lowe1, Lisa Geraci1, Rachelle S Doody3.   

Abstract

OBJECTIVE: Clinicians and researchers who measure cognitive dysfunction often use the Alzheimer's Disease Assessment Scale--Cognitive Subscale (ADAS-Cog), the Mini-Mental State Examination (MMSE), or the Clinical Dementia Rating scale (CDR-SOB). But, the use of different measures can make it difficult to compare data across patients or studies. What is needed is a simple chart that shows how scores on these three important measures correspond to each other.
METHODS: Using data from 1709 participants from the Alzheimer's Disease Neuroimaging Initiative and item response theory-based statistics, we analyzed how scores on each measure, the ADAS-Cog, the MMSE, and the CDR-SOB, correspond.
RESULTS: Results indicated multiple inflections in CDR-SOB and ADAS-Cog scores within a given MMSE score, suggesting that the CDR-SOB and ADAS-Cog are more precise in measuring the severity of cognitive dysfunction than the MMSE.
CONCLUSIONS: This study shows how scores on these three popular measures of cognitive dysfunction correspond to each other, which is very useful information for both researchers and clinicians.

Entities:  

Keywords:  ADAS; Alzheimer’s disease; CDR; Dementia; IRT; MCI; MMSE; Neuropsychological assessment.; Psychometric

Mesh:

Year:  2015        PMID: 26617181     DOI: 10.1080/13854046.2015.1119312

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  26 in total

1.  Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.

Authors:  Nathan A Bihlmeyer; Emily Merrill; Yann Lambert; Gyan P Srivastava; Timothy W Clark; Bradley T Hyman; Sudeshna Das
Journal:  Alzheimers Dement       Date:  2019-03-29       Impact factor: 21.566

2.  Incorporating neurophysiological measures into clinical assessments: Fundamental challenges and a strategy for addressing them.

Authors:  Christopher J Patrick; William G Iacono; Noah C Venables
Journal:  Psychol Assess       Date:  2019-03-21

Review 3.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

4.  Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and Whites.

Authors:  Jia Fan; Marian Tse; Jessie S Carr; Bruce L Miller; Joel H Kramer; Howard J Rosen; Luke W Bonham; Jennifer S Yokoyama
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

5.  Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Hongliang Liu; Michael Lutz; Sheng Luo
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 6.  Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.

Authors:  Reza Majidazar; Erfan Rezazadeh-Gavgani; Saeed Sadigh-Eteghad; Amirreza Naseri
Journal:  Eur J Clin Pharmacol       Date:  2022-07-26       Impact factor: 3.064

7.  Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.

Authors:  Erik C B Johnson; Eric B Dammer; Duc M Duong; Lingyan Ping; Maotian Zhou; Luming Yin; Lenora A Higginbotham; Andrew Guajardo; Bartholomew White; Juan C Troncoso; Madhav Thambisetty; Thomas J Montine; Edward B Lee; John Q Trojanowski; Thomas G Beach; Eric M Reiman; Vahram Haroutunian; Minghui Wang; Eric Schadt; Bin Zhang; Dennis W Dickson; Nilüfer Ertekin-Taner; Todd E Golde; Vladislav A Petyuk; Philip L De Jager; David A Bennett; Thomas S Wingo; Srikant Rangaraju; Ihab Hajjar; Joshua M Shulman; James J Lah; Allan I Levey; Nicholas T Seyfried
Journal:  Nat Med       Date:  2020-04-13       Impact factor: 53.440

8.  The correlation of everyday cognition test scores and the progression of Alzheimer's disease: a data analytics study.

Authors:  Fadi Thabtah; Robinson Spencer; Yongsheng Ye
Journal:  Health Inf Sci Syst       Date:  2020-07-23

9.  Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes.

Authors:  Katherine E Irimata; Brittany N Dugger; Jeffrey R Wilson
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

10.  Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.

Authors:  Siddhesh Zadey; Stephanie S Buss; Katherine McDonald; Daniel Z Press; Alvaro Pascual-Leone; Peter J Fried
Journal:  Neurobiol Aging       Date:  2021-06-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.